Skip to search formSkip to main contentSkip to account menu

20 ML Bupivacaine liposome 13.3 MG/ML Injection [Exparel]

Known as: 20 ML Exparel 13.3 MG/ML Injection, BUPIVACAINE 13.3 mg in 1 mL INFILTRATION INJECTION, SUSPENSION, LIPOSOMAL [EXPAREL], EXPAREL 1.3 % in 20 ML Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Minimally invasive spine surgery has the potential to reduce soft tissue destruction, blood loss, postoperative pain, and overall… 
Highly Cited
2018
Highly Cited
2018
Background: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however… 
2017
2017
Purpose Sustained release hydrogel with bupivacaine (AnestaGel™) is a novel formulation of extended release bupivacaine in a… 
2015
2015
Patients with complex ventral/incisional hernias often undergo an abdominal wall reconstruction (AWR). These operations have a… 
Highly Cited
2013
Highly Cited
2013
Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe… 
Highly Cited
2011
Highly Cited
2011
EXPAREL (bupivacaine extended-release liposome injection), DepoFoam bupivacaine, is in development for prolonged postsurgical…